Sumit Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Sumit Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-10,413	Closed	-$47K	–	220
2013 Q4	$47K	Buy	+10,413	New	+$42.4K	0.08%	198

Other funds holding ATRS

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

WHI

William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

Sumit Capital's ATRS Position: Q1 2014 in Review

Sumit Capital sold out of Antares Pharma, Inc. (ATRS) in Q1 2014, closing a stake of 10,413 shares — an estimated $47K sold.

Sumit Capital first reported a position in ATRS in Q4 2013 and held it in 1 quarter. The position peaked at $47K in Q4 2013. 91 funds tracked by Wall St. Rank hold ATRS as of Q1 2014.

Sumit Capital reported no remaining Antares Pharma, Inc. position as of Q1 2014 after selling out during the quarter.
Sumit Capital sold 10,413 Antares Pharma, Inc. shares in Q1 2014, an estimated $47K.
Sumit Capital first reported a position in Antares Pharma, Inc. in Q4 2013 and held it in 1 quarter.
Sumit Capital's Antares Pharma, Inc. position peaked at $47K in Q4 2013.
91 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2014.

Based on Sumit Capital's 13F filing for Q1 2014, filed 7 May 2014.